Breaking News Instant updates and real-time market news.

PTON

Peloton

$25.96

0.015 (0.06%)

, ALC

Alcon

$58.90

-0.17 (-0.29%)

16:41
11/14/19
11/14
16:41
11/14/19
16:41

Soros adds to Celgene position, lowers Caesars stake, exits Disney

George Soros' Soros Fund Management disclosed in an SEC filing its holdings as of September 30, 2019. Soros' 28 new buys during the third quarter included, by size of position, Peloton (PTON), Alcon (ALC), Ally Financial (ALLY), and Owl Rock Capital (ORCC). Soros exited 33 positions during the quarter, including by size of previous position, Disney (DIS), Vulcan Materials (VMC), and Conagra Brands (CAG). Soros increased its stake in 20 holdings, including by size of previous position, Celgene (CELG), Edgewell Personal Care (EPC), Vistra Energy (VST), Annaly Capital (NLY), and Citigroup (C). Soros reduced its stake in 22 holdings, including by size of previous position, Caesars Entertainment (CZR), Vici Properties (VICI), Morgan Stanley (MS), Archer-Daniels-Midland (ADM), and Liberty Broadband (LBRDK). Soros' top holdings as of September 30, in order of size, were Liberty Broadband, Vici Properties, Caesars Entertainment, Celgene, and Alphabet (GOOGL).

PTON

Peloton

$25.96

0.015 (0.06%)

ALC

Alcon

$58.90

-0.17 (-0.29%)

ALLY

Ally Financial

$30.83

0.15 (0.49%)

ORCC

Owl Rock

$18.20

0.2 (1.11%)

DIS

Disney

$147.19

-1.5 (-1.01%)

VMC

Vulcan Materials

$141.66

3.04 (2.19%)

CAG

Conagra Brands

$28.45

0.13 (0.46%)

CELG

Celgene

$110.03

-0.42 (-0.38%)

EPC

Edgewell Personal Care

$31.40

-0.815 (-2.53%)

VST

Vistra Energy

$26.34

0.34 (1.31%)

NLY

Annaly Capital

$9.11

0.035 (0.39%)

C

Citi

$73.85

-0.06 (-0.08%)

CZR

Caesars

$12.86

0.09 (0.70%)

VICI

VICI Properties

$24.58

0.24 (0.99%)

MS

Morgan Stanley

$48.61

0.22 (0.45%)

ADM

Archer Daniels

$42.78

-0.04 (-0.09%)

LBRDK

Liberty Broadband

$119.07

0.36 (0.30%)

GOOGL

Alphabet Class A

$1,309.61

13.61 (1.05%)

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 02

    Dec

  • 04

    Dec

  • 06

    Dec

  • 07

    Dec

  • 09

    Dec

  • 14

    Jan

  • 25

    Mar

  • 04

    Apr

PTON Peloton
$25.96

0.015 (0.06%)

11/06/19
LEHM
11/06/19
NO CHANGE
Target $33
LEHM
Overweight
Barclays does not see Peloton rally despite 'very encouraging' Q1
Peloton Interactive's "solid" fiscal Q1 results are "very encouraging," but the stock is unlikely to be "rewarded meaningfully," Barclays analyst Deepak Mathivanan tells investors in a post-earnings research note. Sentiment around loss-making initial public offerings with upcoming lock-up expirations "remains sour," and Peloton is likely to be lumped into a similar bucket near-term, says the analyst. With that said, Mathivanan remains bullish on the secular trends in connected fitness and Peloton's long-term competitive position. He raised his price target to $33 from $32 and keeps an Overweight rating on the shares.
10/24/19
10/24/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Peloton (PTON) initiated with an Outperform at Bernstein. 2. Lyft (LYFT) initiated with an Equal Weight at Morgan Stanley. 3. Nektar (NKTR) initiated with a Perform at Oppenheimer. 4. Kellogg (K) initiated with an In Line at Evercore ISI. 5. Pitney Bowes (PBI) initiated with a Buy at National Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/19
BERN
11/14/19
NO CHANGE
Target $29
BERN
Outperform
Lower priced Peloton treadmill could generate higher sales, says Bernstein
Bernstein analyst Jamie Merriman tells investors in a research note that given the high price point of Peloton's connected treadmill Tread, she forecasts limited sales volumes over the next five years, expecting cumulative sales of ~500K compared to ~3.3M bikes additional bikes sold by 2024. However, a lower priced treadmill could generate higher sales dollars, Merriman says. She keeps an Outperform rating and $29 price target on the shares.
11/06/19
BARD
11/06/19
NO CHANGE
Target $29
BARD
Outperform
Peloton weakness a buying opportunity, says Baird
Baird analyst Jonathan Komp continues to recommend the purchase of Peloton shares and views the recent moderate weakness as a buying opportunity. He said he was highly encouraged by its first public company report which featured much better than expected revenue and reduced losses. He believes forward assumptions are conservative given the company's strong brand/product momentum. Komp reiterated his Outperform rating and raised his price target to $29 from $28 on Peloton shares.
ALC Alcon
$58.90

-0.17 (-0.29%)

08/26/19
FBCO
08/26/19
NO CHANGE
Target $73
FBCO
Outperform
Alcon price target raised to $73 from $68 at Credit Suisse
Credit Suisse analyst Matt Miksic raised his price target for Alcon to $73 from $68, citing acceleration in Q2 underlying sales and core op income. The analyst reiterates an Outperform rating on the shares.
10/28/19
SPHN
10/28/19
INITIATION
Target $62
SPHN
Equal Weight
Alcon initiated with an Equal Weight at Stephens
Stephens analyst Chris Cooley initiated coverage of Alcon with an Equal Weight rating and $62 price target. While he has a favorable disposition on the growth prospects for the broad ophthalmic marketplace and views Alcon as a technological innovator, he thinks margin expansion is "less assured" than its revenue growth and notes that the stock is valued at a premium to faster growing peers.
06/24/19
LEER
06/24/19
INITIATION
Target $62
LEER
Market Perform
Alcon initiated with a Market Perform at SVB Leerink
SVB Leerink analyst Richard Newitter initiated Alcon with a Market Perform rating and $62 price target.
11/11/19
REDB
11/11/19
UPGRADE
REDB
Neutral
Alcon upgraded to Neutral from Sell at Redburn
Redburn analyst Ed Ridley-Day upgraded Alcon to Neutral from Sell.
ALLY Ally Financial
$30.83

0.15 (0.49%)

10/08/19
JPMS
10/08/19
DOWNGRADE
Target $33
JPMS
Neutral
Ally Financial downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Richard Shane downgraded Ally Financial to Neutral from Overweight with a price target of $33, down from $35.
10/01/19
PIPR
10/01/19
NO CHANGE
Target $41
PIPR
Overweight
Piper expects beat and raise quarter from Ally Financial in Q3
Piper Jaffray analyst Kevin Barker reiterates an Overweight rating on Ally Financial with a $41 price target ahead of the company's Q3 results. He expects a "strong" beat and raise quarter for Ally due to wider spreads and the continuation of solid credit trends. The company's balance sheet is proving to be better positioned than most other bank peers with deposit costs dropping quickly and asset yields remaining elevated for consumer-facing loans, Barker tells investors in a research note.
09/24/19
MSCO
09/24/19
NO CHANGE
MSCO
Large-cap banks aren't gaining deposit market share, says Morgan Stanley
Morgan Stanley analyst Ken Zerbe said he continues to hear the "false narrative" that large-cap banks must be gaining market share due to their superior technology, but he insists they are not and that small and mid-cap banks have consistently gained deposit market share over the last five years. Individual large-cap banks that have had the biggest deposit share gains include Goldman Sachs (GS), Ally Financial (ALLY) and Synchrony Financial (SYF), while mid-cap banks that have delivered the biggest gains in share of total deposits include First Republic (FRC), KeyCorp (KEY) and Huntington (HBAN), Zerbe tells investors. Large-cap banks that have seen the largest declines in their respective individual shares of total deposits include JPMorgan (JPM), Wells Fargo (WFC) and Citigroup (C), while deposit share losers among mid-cap banks include Comerica (CMA), Prosperity Bancshares (PB) and Zions (ZION), said Zerbe.
10/08/19
JPMS
10/08/19
DOWNGRADE
Target $33
JPMS
Neutral
JPMorgan downgrades Ally Financial on 'reasonably balanced' risks
JPMorgan analyst Richard Shane downgraded Ally Financial to Neutral from Overweight with a price target of $33, down from $35. The company's upside and downside risk are "now reasonably balanced," Shane tells investors in a research note. While the analyst expects "solid" Q3 and Q4 earnings, he believes the "persistent tailwinds" of low unemployment and strong used car prices appear to be fully reflected in forward estimates. This creates a "potentially asymmetric revision profile," says Shane.
ORCC Owl Rock
$18.20

0.2 (1.11%)

11/04/19
WELS
11/04/19
DOWNGRADE
Target $16
WELS
Underperform
Owl Rock downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Finian O'Shea downgraded Owl Rock to Underperform from Market Perform with a $16 price target.
11/05/19
WELS
11/05/19
DOWNGRADE
Target $16
WELS
Underperform
Owl Rock downgraded to Underperform at Wells Fargo on valuation
Wells Fargo analyst Finian O'Shea downgraded Owl Rock to Underperform from Market Perform with a $16 price target, citing valuation. In a research note to investors, O'Shea says that at this juncture, shares have run up to 1.13x NAV just two months out from Owl Rock's first lockup. The analyst says that his view on Owl Rock as a high quality credit platform has not changed, and investment ramp appears reasonably well according to plan, adding that he still believes that Owl Rock's shares transition to the institutional equity market, its strategy and fee structure on upper middle market senior debt will unlikely be compelling at a premium valuation.
11/01/19
LTCO
11/01/19
DOWNGRADE
LTCO
Neutral
Owl Rock downgraded to Neutral from Buy at Ladenburg
Ladenburg analyst Mickey Schleien downgraded Owl Rock Capital to Neutral from Buy without a price target. The analyst cites valuation for the downgrade following the company's Q3 results. He believes the shares are now fairly valued.
10/22/19
RAJA
10/22/19
DOWNGRADE
RAJA
Market Perform
Owl Rock downgraded to Market Perform on valuation at Raymond James
Raymond James analyst Robert Dodd downgraded Owl Rock Capital to Market Perform from Outperform without a price target, citing valuation rather than specific concerns regarding the company, its portfolio, or long-term strategy. In a research note to investors, Dodd says that while he is comfortable with the risk/reward embedded within the company's portfolio strategy, he sees limited additional upside in the shares from current levels.
DIS Disney
$147.19

-1.5 (-1.01%)

11/14/19
RSBL
11/14/19
NO CHANGE
Target $170
RSBL
Buy
Rosenblatt sees potential for high conversion of Disney+ free trials
Rosenblatt analyst Bernie McTernan said Disney's (DIS) announcement of 10M sign ups in the first roughly 36 hours from the launch of Disney+ don't necessarily equate to paying subscribers, but he sees the potential for high conversion of free trials to paying subscribers based on the company's deal with Verizon (VZ) as well as its pacing of show releases. While he acknowledges that Disney shares appear "optically expensive" based on near-term PE multiples, he thinks this misses the potential value Disney is creating in direct-to-consumer services, McTernan added. McTernan has a Buy rating and $170 price target on Disney shares.
11/13/19
WEDB
11/13/19
NO CHANGE
WEDB
Disney's 'jaw dropping' 10M Disney+ subscribers beats expectations, says Wedbush
Wedbush analyst Daniel Ives said Disney's (DIS) just announced 10 million subscribers for Disney+ is a "jaw dropping" figure that he believes is considerably higher than many on Wall Street were anticipating. He also thinks Disney could hit its long term subscriber target of 60 to 90M by s by 2024 potentially two years earlier at this pace. The company's "unmatched content" and "massive" brand and distribution make Disney+ a "legitimate streaming competitor on Day One" to Netflix (NFLX), Ives added. Commenting on the recent launch of Apple's (AAPL) TV+, Ives said pricing, content, and especially the company's installed base remain its "major strategic weapons."
11/13/19
FBCO
11/13/19
NO CHANGE
Target $163
FBCO
Outperform
Disney price target raised to $163 from $150 at Credit Suisse
11/14/19
JPMS
11/14/19
NO CHANGE
Target $160
JPMS
Overweight
JPMorgan ups Disney target to $160 on positive early streaming surprise
JPMorgan analyst Alexia Quadrani raised her price target for Disney to $160 from $150 after the company announced yesterday that Disney+ has reached over 10M subscribers after its launch yesterday in the U.S., Canada, and Netherlands. Disney closed Wednesday up 7%, or $10.14, to $148.72. On November 19, Disney+ will launch in Australia, New Zealand, and Puerto Rico, and will launch in Western Europe on March 31, 2020, Quadrani tells investors in a research note. The analyst is positive on the "early surprise announcement of strong subscriber growth." The announcement surpassed her expectations for 5M subscribers in Q1. Quadrani now expects 15M subscribers in the quarter and bumped up her full year expectations from 15M to 25M. She has "strong conviction" that Disney shares are well positioned to continue to outperform. The analyst keeps an Overweight rating on the stock.
VMC Vulcan Materials
$141.66

3.04 (2.19%)

11/08/19
GSCO
11/08/19
DOWNGRADE
Target $175
GSCO
Buy
Vulcan Materials downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Jerry Revich removed Vulcan Materials from his firm's Conviction List but maintains a Buy rating on the shares. The analyst remains positive on aggregates pricing outlook and infrastructure recovery. However, he believes this view "now appears to be consensus." Revich maintains a $172 price target for the shares.
10/15/19
BOFA
10/15/19
UPGRADE
BOFA
Neutral
Vulcan Materials upgraded to Neutral from Underperform at BofA/Merrill
10/22/19
VERT
10/22/19
INITIATION
Target $160
VERT
Hold
Vulcan Materials initiated with a Hold at Vertical Research
Vertical Research analyst Michael Dudas initiated coverage of Vulcan Materials with a Hold rating and $160 price target.
10/15/19
BOFA
10/15/19
UPGRADE
BOFA
Neutral
Vulcan Materials, Martin Marietta upgraded to Neutral at BofA/Merrill
BofA/Merrill analyst Timna Tanners upgraded Vulcan Materials (VMC) and Martin Marietta (MLM) to Neutral from Underperform. The analyst expects "strong" Q3 results from the building materials names thanks to more accommodating weather driving improved volumes, lower costs, and better pricing. Despite her view that earnings growth may have peaked, Tanners is also modeling her upgrade using "peak multiples" on the stocks and believes that a "sustained re-rating" on the shares is taking place due to improved visibility on growth heading into 2020.
CAG Conagra Brands
$28.45

0.13 (0.46%)

11/14/19
BREN
11/14/19
INITIATION
Target $100
BREN
Buy
Berenberg bullish on plant-based meats, starts Beyond Meat at Buy
Berenberg analyst Donald McLee initiated coverage of three companies involved in the plant-based meat category, which he sees being in the early stages of "its second evolution" as modern plant-protein have progressed significantly toward replicating the experience of animal meat. He started Beyond Meat (BYND) with a Buy rating and $100 price target, identifying it as "the only public, pure-play plant-based meat company." He sees its advantages in innovation, brand awareness, distribution and portfolio making Beyond well-positioned to capture share, McLee tells investors. While he expects strong plant-based trend tailwinds to create a tide that lifts all boats, not all of the competitors in the space are created equal and McLee identifies Conagra's (CAG) Gardein Beyond Meat and Impossible Foods as the three best-positioned plant-based brands.
11/14/19
BREN
11/14/19
INITIATION
Target $29
BREN
Hold
Conagra Brands initiated with a Hold at Berenberg
Berenberg analyst Donald McLee initiated coverage of Conagra Brands with a Hold rating and $29 price target. While the analyst believes Conagra's portfolio leaves it well positioned within "several high-growth food subcategories" over the near term, he expects its shares to be range-bound as the company works toward its intermediate-term goals around margin expansion, deleveraging, and integrating acquisitions.
10/17/19
RBCM
10/17/19
INITIATION
Target $30
RBCM
Sector Perform
Conagra Brands resumed with a Sector Perform at RBC Capital
RBC Capital analyst Nik Modi resumed coverage of Conagra Brands with a Sector Perform rating and $30 price target as part of his broader research note initiating the Packaged Foods sector. The analyst notes that while the management has done well to quickly propose solutions to address the issues around its Pinnacle brands' misperceptions, he believes that the "transformative" deals in the consumer packaged goods space require some "caution". Modi adds that he awaits more signs of the efficacy of Conagra's new innovation.
11/14/19
BREN
11/14/19
INITIATION
Target $29
BREN
Hold
Conagra Brands initiated with a Hold at Berenberg
Berenberg analyst Donald McLee initiated coverage of Conagra Brands with a Hold rating and $29 price target.
CELG Celgene
$110.03

-0.42 (-0.38%)

11/01/19
BARD
11/01/19
DOWNGRADE
Target $101
BARD
Neutral
Celgene downgraded to Neutral at Baird
As reported previously, Baird analyst Brian Skorney downgraded Celgene to Neutral from Outperform. The analyst cited its recent upward move and doesn't see any reason for holding the shares ahead of ASH where any hair out the TRANSCEND data could put the entire CVR at risk. Skorney maintained his $101 price target on Celgene shares.
11/01/19
BARD
11/01/19
DOWNGRADE
Target $101
BARD
Neutral
Celgene downgraded d to Neutral from Outperform at Baird
Baird analyst Brian Skorney downgraded d to Neutral from Outperform with a $101 price target.
09/23/19
GUGG
09/23/19
UPGRADE
Target $55
GUGG
Buy
Agios Pharmaceuticals upgraded to Buy following selloff at Guggenheim
Guggenheim analyst Michael Schmidt upgraded Agios Pharmaceuticals (AGIO) to Buy from Neutral following a 20% year-to-date selloff in the shares, stating that the current valuation reflects no value beyond Tibsovo and Idhifa. Even with more conservative estimates, he believes Tibsovo alone is worth $35 per share and Idhifa royalties from Celgene (CELG) are worth $4, giving the stock a one-year "floor valuation" of $39 per share. Meanwhile, feedback from doctors highlights a moderate but "real" commercial opportunity in PKD for Mitapivat, said Schmidt, who set a $55 price target on Agios shares.
11/01/19
STPT
11/01/19
DOWNGRADE
STPT
Hold
Celgene downgraded to Hold from Buy at Standpoint Research
Standpoint Research analyst Ronnie Moas downgraded Celgene to Hold from Buy.
EPC Edgewell Personal Care
$31.40

-0.815 (-2.53%)

07/08/19
RHCO
07/08/19
UPGRADE
Target $40
RHCO
Buy
Edgewell Personal Care upgraded to Buy from Hold at SunTrust
SunTrust analyst William Chappell upgraded Edgewell Personal Care to Buy from Hold and raised his price target for the shares to $40 from $35.
03/04/19
RHCO
03/04/19
NO CHANGE
Target $45
RHCO
Hold
Edgewell Personal Care price target raised to $45 from $40 at SunTrust
SunTrust analyst William Chappell raised his price target on Edgewell Personal Care to $45 after traveling with its newly appointed CEO Rod Little to meet with investors. The analyst says the discussions have given him a greater appreciation for the current wet shave market dynamics, the decision to divest the FemCare and Infant Care businesses, and the initiatives being taken to improve top and bottom line growth. Chappell also believes that the "worst of the storm" around "commodity pressures, adverse FX, and new competition" is now in the past. The analyst keeps his Hold rating on Edgewell Personal Care however in expectation of the competitive wet shave business and a protracted turnaround in the company's Infant Care and Feminine Care segments.
07/08/19
07/08/19
UPGRADE
Target $40

Buy
Edgewell Personal Care upgraded to Buy from Hold at SunTrust
As previously reported, SunTrust analyst William Chappell upgraded Edgewell Personal Care to Buy from Hold and raised his price target to $40 from $35. The analyst maintains his view that the company's $1.4B deal to acquire Harry's "makes sense" even though the stock price fell 16% when the acquisition was announced in May, as it "immediately returns" Edgewell to prominence in the US wet shave category, adding that the opportunity toward gains in market share and profitability offsets the deal's near term risks. Chappell adds that the current valuation on the shares is too low, with upside catalysts that include a stabilizing legacy business in Q3 and a potential divestitures of the company's Infant and Feminine Care assets.
05/10/19
RHCO
05/10/19
NO CHANGE
Target $35
RHCO
Hold
Edgewell Personal Care price target lowered to $35 from $45 at SunTrust
SunTrust analyst William Chappell lowered his price target on Edgewell Personal Care to $35 to reflect the "high leverage" assumed in its Harry's deal and the high price paid for the combination. While he is positive on the company implementing a marketing overhaul for Harry's, he keeps his Hold rating on the stock given that the deal closing is still months away.
VST Vistra Energy
$26.34

0.34 (1.31%)

09/06/19
MSCO
09/06/19
NO CHANGE
MSCO
Morgan Stanley cuts Entergy, ups NRG in U.S. Utilities preference shuffle
As previously reported, Morgan Stanley analyst Stephen Byrd downgraded Entergy (ETR) to Equal Weight from Overweight while raising his price target for the shares to $115 from $114. He also upgraded NRG Energy (NRG) to Overweight from Equal Weight and raised his price target for the shares to $49 from $47. Sector outperformance relative to the broader market has resulted in a very high relative valuation for the lowest risk stocks, leaving opportunities to invest in U.S. utility stocks that have been "left behind," contends Byrd. Entergy has outperformed the UTY index year-to-date by about 14%, while NRG has underperformed by 16% year-to-date versus its closest peer, Vistra Energy (VST), explained Byrd. He also increased his price target on Xcel Energy (XEL) to $63 from $60, on Ameren (AEE) to $80 from $78 and on CMS Energy (CMS) to $63 from $59 as he sees these Midwest utilities offering above-average earnings growth. Byrd still recommends investors avoid utility stocks with "fat tail risks," including Edison International (EIX), PG&E (PCG), Pinnacle West (PNW) and Southern (SO).
05/08/19
BOFA
05/08/19
DOWNGRADE
BOFA
Neutral
Vistra Energy downgraded to Neutral from Buy at BofA/Merrill
05/08/19
BOFA
05/08/19
DOWNGRADE
Target $28
BOFA
Neutral
Vistra Energy downgraded to Neutral on Texas market caution at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Julien Dumoulin-Smith downgraded Vistra Energy to Neutral from Buy as he is cautious about upcoming datapoints around Texas power supply/demand and also sees some downside to PJM capacity auction prices off recent highs. The analyst, who is now basing his valuation of Vistra on a free cash flow approach, trimmed his price target on the stock to $28 from $29.
11/07/19
BOFA
11/07/19
UPGRADE
Target $31
BOFA
Buy
Vistra Energy upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith upgraded Vistra Energy to Buy from Neutral with a $31 price target. The pullback in the shares post the company's Q3 results is "quite disconnected" from the recent uptick in both Electric Reliability Council of Texas power forwards and PJM Interconnection spark spreads, Dumoulin-Smith tells investors in a research note. The analyst believes the Street is underestimating the impact of higher power prices for Vistra Energy.
NLY Annaly Capital
$9.11

0.035 (0.39%)

10/02/19
RBCM
10/02/19
INITIATION
RBCM
Outperform
Annaly Capital initiated with an Outperform at RBC Capital
10/02/19
RBCM
10/02/19
INITIATION
Target $10
RBCM
Outperform
Annaly Capital initiated with an Outperform at RBC Capital
RBC Capital analyst Kenneth Lee initiated Annaly Capital with an Outperform and $10 price target.
10/02/19
RBCM
10/02/19
INITIATION
RBCM
RBC Capital initiates select mortgage REITs with 'constructive' outlook
RBC Capital analyst Kenneth Lee initiated select names in the Mortgage REIT sector with a "constructive" outlook, saying they offer an opportunity amid a "challenging" interest rate environment. Lee assigned a Buy rating to Annaly Capital Management (NLY) with a $10 price target, Chimera Investment (CIM) with a $21 price target, MFA Financial (MFA) with a $8 price target and Two Harbors Investment (TWO) with a $15 price target, while also starting AGNC Investment (AGNC) at Outperform with a $16 price target. The analyst contends that the housing market conditions remain "favorable" with continued home price appreciation and mortgage delinquencies still being very benign, which benefits the mortgage credit industry. Lee also notes that opportunities for mortgage REITs to deploy capital with attractive risk-adjusted returns still exist and the shares are attractive to yield-oriented investors looking for low betas. Among the names listed, the analyst sees Annaly Capital Management as his "favorite idea" thanks to its diversified investment strategy, while noting that AGNC Investment is constrained by higher relative sensitivity to interest rate risk.
09/03/19
UBSW
09/03/19
DOWNGRADE
Target $8
UBSW
Neutral
Annaly Capital downgraded to Neutral from Buy at UBS
UBS analyst Brock Vandervliet downgraded Annaly Capital to Neutral and lowered his price target to $8 from $9.50, citing a "more hostile" interest rate environment. The analyst notes that Mortgage REITs is the most interest rate sensitive sector and contends that investment factors for Annaly Capital are different from the time when he initiated the stock in mid-June as the treasury yield curve not only flattened but inverted.
C Citi
$73.85

-0.06 (-0.08%)

10/16/19
BMOC
10/16/19
NO CHANGE
Target $57
BMOC
Market Perform
Wells Fargo price target lowered to $57 from $59 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Wells Fargo (WFC) to $57 and kept his Market Perform rating after its Q3 results. The analyst cites the bank's lower than expected net interest income along with a miss on fees and a higher than anticipated operating costs. Fotheringham contends that before the new Wells Fargo CEO arrives and administers a strategic review, there are better investment opportunities in large cap banks that include Citi (C), Bank of America (BAC), Capital One (COF) and Morgan Stanley (MS).
11/07/19
BOFA
11/07/19
NO CHANGE
Target $85
BOFA
Buy
Citi price target raised to $85 from $78 at BofA/Merrill
BofA/Merrill analyst Erika Najarian raised her price target on Citi to $85 and kept her Buy rating, saying the company's "renewed U.S. consumer strategy" may help in its transition to a "story stock" from a "value stock". The analyst cites Citi's recent progress and forward vision of its new Head of Consumer Banking, Anand Selva, in growing its Branded Cards business, boosting her confidence in her FY20 projections.
10/24/19
10/24/19
NO CHANGE

Citigroup to hold a conference call
Conference call to discuss 3Q19 Fixed Income Investor Review will be held on October 29 at 11 am. Reference Link
CZR Caesars
$12.86

0.09 (0.70%)

06/25/19
MSCO
06/25/19
DOWNGRADE
Target $12.5
MSCO
Equal Weight
Caesars downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Thomas Allen downgraded Caesars (CZR) to Equal Weight from Overweight with a $12.50 price target after the company agreed to be acquired by Eldorado Resorts (ERI). While he sees a potential bull case to $15 per share where the market values Caesars at Friday's multiples inclusive of the greater than $500M of synergies expected for the merger, Allen said he also sees a less likely bear case of $9 per share if the deal were to fall apart.
07/01/19
DBAB
07/01/19
NO CHANGE
Target $74
DBAB
Buy
Eldorado Resorts price target raised to $74 from $56 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli raised his price target for Eldorado Resorts (ERI) to $74 from $56 following the company's acquisition of Caesars Entertainment (CZR). The combined entity, from a financial perspective, "harmonizes nicely" and generates "considerable" free cash flow, which, if valued properly relative to peers, implies "meaningful upside" in the shares, Santarelli tells investors in a research note. He keeps a Buy rating on both Eldorado and Caesars.
08/26/19
08/26/19
UPGRADE
Target $26

Overweight
VICI Properties raised to Overweight at Morgan Stanley on non-gaming opportunity
As previously reported, Morgan Stanley analyst Thomas Allen upgraded VICI Properties (VICI) to Overweight from Equal Weight and raised his price target to $26 from $25. The analyst notes that the stock has underperformed since the merger announcement between Eldorado Resorts (ERI) and Caesars Entertainment (CZR) on concerns that the deal will result in greater tenant risk, but he believes that it makes Caesar's rent "better covered by free cash flows" in a recession and that the underperformance is overdone. Allen also cites the company's recent investor presentation highlighting its non-gaming asset expansion opportunity.
06/25/19
WOLF
06/25/19
UPGRADE
WOLF
Outperform
Eldorado Resorts upgraded to Outperform from Peer Perform at Wolfe Research
Wolfe Research upgraded Eldorado Resorts (ERI) to Outperform from Peer Perform saying the acquisition of Caesars (CZR) is favorable in terms of deal synergies and resulting weakness has provided a buying opportunity.
VICI VICI Properties
$24.58

0.24 (0.99%)

11/11/19
NOMU
11/11/19
NO CHANGE
Target $45
NOMU
Neutral
Gaming REITs remain in early stages of re-rating, says Nomura Instinet
Nomura Instinet analyst Daniel Adam believes the Gaming Real Estate Investment Trust space is still in the early stages of an industry re-rating. The analyst raised his price target for Neutral-rated Gaming and Leisure Properties (GLPI) to $45 from $42, for Buy-rated MGM Growth (MGP) to $43 from $40 and for Buy-rated VICI Properties (VICI) to $35 from $32.
09/24/19
GSCO
09/24/19
UPGRADE
Target $155
GSCO
Buy
Wynn Resorts upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Stephen Grambling upgraded Wynn Resorts (WYNN) to Buy from Neutral and raised his price target for the shares to $155 from $140. The company's free cash flow is set to inflect as major capital projects are completed, Grambling tells investors in a research note. Further, Wynn's projects ramping in Boston and Las Vegas should provide domestic growth while leading indicators and recent data points suggest Macau gaming revenue is stabilizing with potential for upside, adds the analyst. Grambling raised price targets across the gaming space for those companies exposed to Macau. The space is set for outperformance, says the analyst, who now has Buy ratings on Las Vegas Sands (LVS), Red Rock Resorts (RRR), VICI Properties (VICI) and Wynn Resorts.
08/26/19
08/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Dish (DISH) double upgraded to Strong Buy from Market Perform at Raymond James with analyst Richard Prentiss saying following the recent pullback on investor concerns about the shift from a spectrum bank to a wireless operator, now is the "opportune time" to buy shares of Dish. 2. Lyft (LYFT) upgraded to Buy from Neutral at Guggenheim with analyst Jake Fuller saying improving U.S. ride hail competitive dynamics and Lyft's "surprising leverage to that trend" should allow the company to reach EBITDA positive in 2021 versus prior expectations of 2023. 3. Canopy Growth (CGC) upgraded to Buy from Neutral at Seaport Global with analyst Brett Hundley saying Canopy shares have now "round-tripped themselves" year-to-date, and are down 7.4% compared to a 13.6% increase in the S&P 500. 4. Copel (ELP) upgraded to Overweight from Neutral at JPMorgan with analyst Fernando Abdalla saying the company's cash flows are expanding in 2019 and its leverage coming down with the start-up of important greenfield projects. 5. VICI Properties (VICI) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Thomas Allen saying the stock has underperformed since the merger announcement between Eldorado Resorts (ERI) and Caesars Entertainment (CZR) on concerns that the deal will result in greater tenant risk, but he believes that it makes Caesar's rent "better covered by free cash flows" in a recession and that the underperformance is overdone. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MS Morgan Stanley
$48.61

0.22 (0.45%)

10/29/19
ODEN
10/29/19
DOWNGRADE
ODEN
Hold
Morgan Stanley downgraded to Hold from Buy at Odeon Capital
Odeon Capital analyst Richard Bove downgraded Morgan Stanley to Hold from Buy. While he views CEO James Gorman as among "the best and the brightest" on Wall Street, Bove believes the bank is now in a "very difficult situation" as its Asset and Wealth Management and Trading businesses are facing "price destruction due to technology." Also, the bank has slowed the growth in it common equity "at a time when recurring revenue streams from capital intensive lending are very necessary," Bove tells investors.
10/10/19
10/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Apple (AAPL) upgraded to Buy from Neutral at Longbow with analyst Shawn Harrison saying his contacts, who previously gave him initial conservative forecasts for up to a 10% year-over-year decline in iPhone production in the calendar third quarter, now see flat production in the period of Apple's fiscal fourth quarter. 2. Qorvo (QRVO) and Skyworks (SWKS) upgraded to Outperform from Market Perform at Cowen. 3. Allegheny Technologies (ATI) upgraded to Buy from Neutral at Goldman Sachs with analyst Matthew Korn saying Allegheny is one of few stocks in the sector with sales growth that does not depend on a commodity price recovery. 4. Bed Bath & Beyond (BBBY) upgraded to Outperform from Market Perform at Telsey Advisory. 5. Morgan Stanley (MS) upgraded to Buy from Hold at Sandler O'Neill with analyst Jeffery Harte citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage click here.
10/14/19
KBWI
10/14/19
NO CHANGE
KBWI
Hard for Goldman, Morgan Stanley to justify E-Trade deal, says Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl looked into whether an acquisition of E-Trade (ETFC) would make sense for Goldman Sachs (GS) or Morgan Stanley (MS) after the electronic brokers reduced their commission rates. The analyst says he could make the strategic rationale for why a broker would buy an e-broker, namely cost savings and customer base expansion. However, ultimately a deal has to make sense financially as well, and it would be hard for Morgan or Goldman to justify on this basis, Kleinhanzl tells investors in a research note. In addition, with both brokers trading near tangible book value, shareholders would prefer buybacks versus an acquisition as a better use of shareholder capital at this point in the cycle, adds the analyst. As such a result, Kleinhanzl sees a deal for E-Trade as unlikely given the financial and capital impacts. He would be surprised if either broker aggressively pursued E-Trade as an acquisition.
ADM Archer Daniels
$42.78

-0.04 (-0.09%)

07/12/19
BARD
07/12/19
NO CHANGE
BARD
Outperform
Darling Ingredients named a Fresh Pick at Baird
Baird analyst Ben Kallo named Darling Ingredients (DAR) as a Fresh Pick as he believes a rally in fat pricing should be a tailwind for the balance of the year. While he is more positive on Darling (DAR), Kallo said weather, trade, and African swine fever combine to make challenging ag environment more broadly and he is cautious in the near-term on Archer Daniels (ADM), Bunge (BG) and FMC Corporation (FMC). He keeps Outperform ratings on Darling and Archer and Neutral ratings on Bunge and FMC.
08/26/19
BARD
08/26/19
NO CHANGE
BARD
Outperform
Archer Daniels weakness a buying opportunity, says Baird
Baird analyst Ben Kallo said the recent weakness in Archer Daniels has created a compelling entry point. The analyst said significant macro headwinds have been priced in and he think s the Readiness Initiatives and historical investments in Nutrition may be underappreciated. Kallo reiterated his Outperform rating and $48 price target on Archer Daniels shares.
10/07/19
SPHN
10/07/19
INITIATION
Target $50
SPHN
Overweight
Stephens starts Archer Daniels at Overweight with $50 price target
As previously reported, Stephens analyst Ben Bienvenu initiated coverage of Archer Daniels with an Overweight rating and $50 price target. Fundamentals have been under pressure due to investments in future growth and current uncertainty in the global trade environment, but he thinks patient, value-oriented investors have a solid entry point at current levels into a company paying a healthy dividend while new businesses mature and the company's "more normalized" earnings power returns.
10/07/19
SPHN
10/07/19
INITIATION
Target $50
SPHN
Overweight
Archer Daniels initiated with an Overweight rating at Stephens
Stephens analyst Ben Bienvenu initiated coverage of Archer Daniels with an Overweight rating and $50 price target.
LBRDK Liberty Broadband
$119.07

0.36 (0.30%)

10/04/19
SBSH
10/04/19
INITIATION
Target $125
SBSH
Buy
Citi starts Liberty Broadband with a Buy rating, $125 price target
Citi analyst Michael Rollins initiated coverage of Liberty Broadband (LBRDK) with a Buy rating and $125 price target. At the current market value for Charter (CHTR) shares, Liberty Broadband is trading at a net asset value discount of about 12% to fair value, Rollins tells investors in a research note. As such, the analyst believes Liberty Broadband may serve as a more compelling investment opportunity in Charter's operating performance.
07/18/19
TDSI
07/18/19
DOWNGRADE
TDSI
Hold
Liberty Broadband downgraded to Hold from Buy at TD Securities
08/09/19
TDSI
08/09/19
UPGRADE
TDSI
Buy
Liberty Broadband upgraded to Buy from Hold at TD Securities
10/04/19
SBSH
10/04/19
INITIATION
Target $125
SBSH
Buy
Liberty Broadband initiated with a Buy rating at Citi
Citi analyst Michael Rollins initiated coverage of Liberty Broadband with a Buy rating and $125 price target.
GOOGL Alphabet Class A
$1,309.61

13.61 (1.05%)

11/08/19
DADA
11/08/19
NO CHANGE
Target $44
DADA
Buy
TripAdvisor price target lowered to $44 from $55 at DA Davidson
DA Davidson analyst Tom White lowered his price target on TripAdvisor (TRIP) to $44 after its "disappointing" Q3 results as the company's core Hotels, Media & Platform segment revenue fell 12% while leading to a cut in its 2019 EBITDA growth outlook to "single-digits" from "double-digit". The analyst notes that the competitive Google (GOOGL) SEO issues are unlikely to abate in 2020, but he is keeping his Buy rating on the stock, noting that Tripadvisor is making progress in accelerating its ongoing transformation into a hotel/lodging business that relies less on auction-based ad spend.
11/11/19
UBSW
11/11/19
NO CHANGE
Target $240
UBSW
Buy
Nvidia price target raised to $240 ahead of earnings, DC product launch at UBS
UBS analyst Timothy Arcuri raised his price target on Nvidia shares to $240 from $195 ahead of the company's October quarter earnings report. He models quarterly revenue and EPS of $2.91B and $1.61, respectively, which he notes is "more or less" in-line with consensus, but he still sees a path higher for the stock despite the fact that it has outperformed both the S&P 500 and S&P 500 Semis by a "wide margin" over the last three months. Data is starting to play out to prove strength in gaming as ray tracing becomes standard and in the data center as the new 7nm product should be announced next week, said Arcuri. He thinks "performance-focused" customers like Google (GOOGL) are waiting for this new 7nm product and that others are building it into their 2020 roadmaps, the analyst added.
11/11/19
LOOP
11/11/19
NO CHANGE
Target $1450
LOOP
Hold
Alphabet price target raised to $1,450 from $1,350 at Loop Capital
Loop Capital analyst Alan Gould raised his price target on Alphabet to $1,450, rolling forward his valuation model to 2021 and noting that the company's fundamentals remains strong while its growth in advertising revenue continues at unprecedented scale. The analyst is keeping his Hold rating on Alphabet however, stating that the current regulatory environment poses a growing challenge with no expected improvement over the next 12 months.
11/14/19
RHCO
11/14/19
NO CHANGE
Target $43
RHCO
Buy
TripAdvisor price target lowered to $43 from $60 at SunTrust
SunTrust analyst Naved Khan lowered his price target on TripAdvisor (TRIP) to $43 after its Q3 earnings miss reported last week. The analyst says he was mistaken in expecting stabilization in the company's Hotels, Media & Platform segment and also underestimated the SEO risk from Google (GOOGL). Khan is keeping his Buy rating on TripAdvisor stock however, stating that its Experiences/Dining business accounts for the "bulk" of its intrinsic value and represents the primary reason to hold the shares.

TODAY'S FREE FLY STORIES

FITB

Fifth Third

$30.24

0.365 (1.22%)

, CSCO

Cisco

$43.83

0.29 (0.67%)

18:37
12/06/19
12/06
18:37
12/06/19
18:37
Hot Stocks
Fifth Third issues statement on temporary network outage »

Fifth Third Bank (FITB)…

FITB

Fifth Third

$30.24

0.365 (1.22%)

CSCO

Cisco

$43.83

0.29 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 12

    Dec

  • 08

    Jan

  • 12

    Feb

STML

Stemline

$10.33

0.5 (5.09%)

, PFE

Pfizer

$38.29

0.26 (0.68%)

18:33
12/06/19
12/06
18:33
12/06/19
18:33
Hot Stocks
Stemline names Robert Francomano as Chief Commercial Officer »

Most recently, Francomano…

STML

Stemline

$10.33

0.5 (5.09%)

PFE

Pfizer

$38.29

0.26 (0.68%)

GSK

GlaxoSmithKline

$45.51

0.29 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

  • 11

    Dec

GOL

Gol Linhas

$17.39

1.07 (6.56%)

18:31
12/06/19
12/06
18:31
12/06/19
18:31
Hot Stocks
Gol Linhas announces preliminary traffic figures for November »

GOL's domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVB

Navidea

$0.97

0.07 (7.78%)

18:25
12/06/19
12/06
18:25
12/06/19
18:25
Syndicate
Navidea announces $1.9M private placement »

Navidea announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFC

Ellington Financial

$18.22

0.09 (0.50%)

18:23
12/06/19
12/06
18:23
12/06/19
18:23
Hot Stocks
Ellington Financial reports estimated book value per share $18.51 on November 30 »

This estimate includes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOT

Boot Barn

$41.93

0.81 (1.97%)

18:22
12/06/19
12/06
18:22
12/06/19
18:22
Hot Stocks
Boot Barn CEO: More than 80% of our business is in the store »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIC

Ericsson

$9.24

0.1 (1.09%)

18:18
12/06/19
12/06
18:18
12/06/19
18:18
Hot Stocks
Ericsson to pay over $1B to settle FCPA case »

Ericsson has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GLD

SPDR Gold Shares

$137.59

-1.42 (-1.02%)

17:55
12/06/19
12/06
17:55
12/06/19
17:55
Hot Stocks
SPDR Gold Shares holdings fall to 886.23MT from 888.57MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PICO

PICO Holdings

$10.81

0.31 (2.95%)

17:45
12/06/19
12/06
17:45
12/06/19
17:45
Hot Stocks
PICO Holdings sells long-term storage credits for $8.7M in Arizona »

PICO Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QHC

Quorum Health

$0.95

0.0522 (5.81%)

17:31
12/06/19
12/06
17:31
12/06/19
17:31
Hot Stocks
Quorum Health receives NYSE continued listing standard notice »

Quorum Health Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:30
12/06/19
12/06
17:30
12/06/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXRX

Baudax Bio

$6.69

0.34 (5.35%)

17:29
12/06/19
12/06
17:29
12/06/19
17:29
Syndicate
Breaking Syndicate news story on Baudax Bio »

Baudax Bio files $125M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

LMT

Lockheed Martin

$387.10

1.175 (0.30%)

17:25
12/06/19
12/06
17:25
12/06/19
17:25
Hot Stocks
Lockheed Martin awarded $153.39M Navy contract modification »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$71.72

1.27 (1.80%)

17:23
12/06/19
12/06
17:23
12/06/19
17:23
Syndicate
Breaking Syndicate news story on Envestnet »

Envestnet files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$344.79

0.4 (0.12%)

17:20
12/06/19
12/06
17:20
12/06/19
17:20
Hot Stocks
Northrop Grumman awarded $189M Navy contract modification »

Northrop Grumman was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:03
12/06/19
12/06
17:03
12/06/19
17:03
Hot Stocks
Support.com announces special distribution of $1.00 per share »

The record date for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:01
12/06/19
12/06
17:01
12/06/19
17:01
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RZLT

Rezolute

$0.00

(0.00%)

17:00
12/06/19
12/06
17:00
12/06/19
17:00
Syndicate
Breaking Syndicate news story on Rezolute »

Rezolute files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,750.79

10.2 (0.59%)

16:58
12/06/19
12/06
16:58
12/06/19
16:58
Periodicals
U.S. mulls putting Amazon foreign sites on 'Notorious Markets' list, WSJ says »

The Trump administration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGTA

Magenta Therapeutics

$13.29

0.3 (2.31%)

16:55
12/06/19
12/06
16:55
12/06/19
16:55
Conference/Events
Magenta Therapeutics to hold an investor and analyst event »

Investor and Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

IMH

IMPAC Mortgage

$5.63

-0.01 (-0.18%)

16:54
12/06/19
12/06
16:54
12/06/19
16:54
Syndicate
Breaking Syndicate news story on IMPAC Mortgage »

IMPAC Mortgage files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.74

0.33 (1.70%)

16:32
12/06/19
12/06
16:32
12/06/19
16:32
Hot Stocks
Alector reports Phase 1 safety, biomaker data on AL002 »

Alector reported safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATAX

America First Multifamily Investors

$7.58

0.125 (1.68%)

16:31
12/06/19
12/06
16:31
12/06/19
16:31
Hot Stocks
America First Multifamily Investors CFO Craig Allen to retire »

On December 2,Craig Allen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
12/06/19
12/06
16:30
12/06/19
16:30
Options
Preliminary option volume of 20.4M today »

Preliminary option volume…

PNM

PNM Resources

$48.77

-0.06 (-0.12%)

16:29
12/06/19
12/06
16:29
12/06/19
16:29
Hot Stocks
PNM Resources raises quarterly dividend 6% to 30.75c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.